Usana Health Sciences (USNA) Net Cash Flow (2011 - 2026)

Usana Health Sciences (USNA) has 16 years of Net Cash Flow data on file, last reported at $3.5 million in Q2 2026.

• Net Cash Flow for Q2 2026 came in at $3.5 million, up 223.11% year-over-year; the trailing twelve-month figure through Apr 2026 was -$22.0 million (up 85.04% YoY), and the FY2026 annual result was -$28.4 million, up 80.09% from the prior year.
• Net Cash Flow eased to $3.5 million in Q2 2026 per USNA's latest filing, from $11.2 million in the prior quarter.
• Over five years, Net Cash Flow peaked at $37.0 million in Q4 2022 and troughed at -$176.4 million in Q4 2024.
• A 5-year average of -$9.8 million and a median of $4.3 million in 2024 frame the typical range for Net Cash Flow.
• The sharpest annual moves came in 2023 and 2024: Net Cash Flow soared 1542.61% in 2023, then plunged 1011.32% in 2024.
• A 5-year view of Net Cash Flow shows it stood at $37.0 million in 2022, then plunged by 47.72% to $19.4 million in 2023, then sank by 1011.32% to -$176.4 million in 2024, then jumped by 96.52% to -$6.1 million in 2025, then surged by 157.36% to $3.5 million in 2026.
• Business Quant data shows USNA's Net Cash Flow at $3.5 million in Q2 2026, $11.2 million in Q1 2026, and -$6.1 million in Q3 2025.